Rheumatology

Neuro-infectious disease

Questions discussed in this category

What are the current treatment options for progressive multifocal leukoencephalopathy in patients without HIV/AIDS?

Are there any clinical trials underway to study additional therapies?

1 Answer available

What is your preferred first-line treatment for chronic fatigue in patients with long COVID-19?

7 Answers available

When would you consider checking JC virus prior to initiating biologic therapy?

1 Answer available

Papers discussed in this category

Journal of neurovirology, 2018-06

Progressive multifocal leukoencephalopathy in rituximab-treated rheumatic diseases: a rare event.

Medical sciences (Basel, Switzerland), 2018-09-21

Low-Dose Naltrexone (LDN)-Review of Therapeutic Utilization.

The Journal of clinical investigation, 2021 Dec 15

The intersection of COVID-19 and autoimmunity.

Molecular systems biology, 2023 Mar 15

A methylation clock model of mild SARS-CoV-2 infection provides insight into immune dysregulation.

BMJ open, 2024 May 13

Low-dose naltrexone for post-COVID fatigue syndrome: a study protocol for a double-blind, randomised trial in British Columbia.

Related Topics in Rheumatology